Bifidobacterium pseudocatenulatum and its metabolite 5-aminovaleric acid betaine decline with age and, when restored, reduce inflammatory aging markers and extend healthspan in mice. This identifies a specific microbial-metabolic pathway linking microbiome composition to systemic inflammation and longevity.
Key Points
- B. pseudocatenulatum and its metabolite decline significantly with age
- Restoring both reduces inflammaging and extends mouse healthspan
- Identifies microbiome-metabolite pathway underlying age-related inflammation
Longevity Analysis
Chronic low-grade inflammation drives multiple age-related diseases and represents a core target in longevity medicine. This work maps a specific microbial strain and its metabolic product as regulators of this inflammatory state, suggesting that microbiome composition is not merely a marker of aging but an active determinant of it. The decline of B. pseudocatenulatum with age points to a restorable functional deficiency—one that may be addressable through strategic intervention rather than accepted as inevitable. Understanding which microbial populations and their end products maintain immune tolerance and metabolic homeostasis during aging opens a rational approach to microbiome optimization centered on measurable metabolite abundance rather than broad microbial diversity metrics alone.
Original published by Nature Aging, by Xiaoyong Lu.